192 related articles for article (PubMed ID: 20549480)
1. [Methods and means for pigmentation and depigmentation. Sense or nonsense?].
Hegyi V; Hegyi J
Hautarzt; 2010 Jul; 61(7):586-92. PubMed ID: 20549480
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of light-induced hyperpigmentation of the skin with hydroquinone monobenzyl ester].
Lur'e VG; Lur'e IV
Vestn Dermatol Venerol; 1968 Feb; 42(2):84-6. PubMed ID: 5741236
[No Abstract] [Full Text] [Related]
3. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.
Kang HY; Valerio L; Bahadoran P; Ortonne JP
Am J Clin Dermatol; 2009; 10(4):251-60. PubMed ID: 19489658
[TBL] [Abstract][Full Text] [Related]
4. Topical chemotherapy of pigment abnormalities in surgical patients.
Gilchrest BA; Goldwyn RM
Plast Reconstr Surg; 1981 Apr; 67(4):435-9. PubMed ID: 7208685
[TBL] [Abstract][Full Text] [Related]
5. A new formula for depigmenting human skin.
Kligman AM; Willis I
Arch Dermatol; 1975 Jan; 111(1):40-8. PubMed ID: 1119822
[TBL] [Abstract][Full Text] [Related]
6. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
McGuinn KP; Saedi N; Green JB; Dover JS
Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
[No Abstract] [Full Text] [Related]
7. Topical use of hydroquinone for depigmentation.
Spencer MC
JAMA; 1965 Nov; 194(9):962-4. PubMed ID: 5897964
[No Abstract] [Full Text] [Related]
8. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
Ladizinski B; Mistry N; Kundu RV
Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hyperpigmentations of the skin with hydroguinone (depigmentation ointment)].
Peisert E; Król C
Przegl Dermatol; 1972; 59(2):205-9. PubMed ID: 5023356
[No Abstract] [Full Text] [Related]
10. Treatment of a pigmented lesion induced by a Pelagia noctiluca sting.
Kokelj F; Burnett JW
Cutis; 1990 Jul; 46(1):62-4. PubMed ID: 1974491
[TBL] [Abstract][Full Text] [Related]
11. Depigmentation with tert-butyl hydroquinone using black guinea pigs.
Patrick E; Juberg DR; O'Donoghue J; Maibach HI
Food Chem Toxicol; 1999; 37(2-3):169-75. PubMed ID: 10227740
[TBL] [Abstract][Full Text] [Related]
12. Aesthetic problems associated with the cosmetic use of bleaching products.
Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
[TBL] [Abstract][Full Text] [Related]
13. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
Cook-Bolden FE; Hamilton SF
Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
[TBL] [Abstract][Full Text] [Related]
14. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
[TBL] [Abstract][Full Text] [Related]
15. Cosmetic and dermatology: bleaching creams.
Engasser PG; Maibach HI
J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611
[TBL] [Abstract][Full Text] [Related]
16. Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma.
Gano SE; Garcia RL
Cutis; 1979 Feb; 23(2):239-41. PubMed ID: 421493
[TBL] [Abstract][Full Text] [Related]
17. [Topical treatment of hyperpigmentation disorders].
Rendon M; Horwitz S
Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S102-7. PubMed ID: 23260517
[TBL] [Abstract][Full Text] [Related]
18. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
Tse TW
J Dermatolog Treat; 2010 Sep; 21(5):272-5. PubMed ID: 20095963
[TBL] [Abstract][Full Text] [Related]
19. [Experience in the treatment of hyperpigmentation of facial skin with hydroquinone monobenzyl ether].
Gusarova AS; Zalem ZIa
Vestn Dermatol Venerol; 1966 Mar; 40(3):49-52. PubMed ID: 5988245
[No Abstract] [Full Text] [Related]
20. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
